R-Lume 40mg/240mg Tablet: Treats Malaria in Adults and Children

Introducing R-Lume 40/240

R-Lume 40/240 provides a powerful combination of Artemether 40mg and Lumefantrine 240mg tablets, designed to combat malaria effectively, even in areas resistant to chloroquine. This medication is well-tolerated and has demonstrated high cure rates, particularly in regions with multi-drug resistance.

Key Benefits

• First-Line Treatment: Recommended by the CDC as the first-choice treatment for uncomplicated malaria caused by P. falciparum.
• WHO Prequalification: Meets WHO criteria for efficacy, safety, and quality as the first artemisinin-based fixed-dose combination.
• Meal-Dependent Absorption: Absorption of artemether and lumefantrine is enhanced with food intake, ensuring optimal therapeutic effectiveness.
• Effective Regimen: A six-dose course is effective in rapidly reducing parasite counts and achieving high cure rates in uncomplicated falciparum malaria.

Why Choose R-Lume 40/240?

• Superior Formulation: Contains higher doses of artemether and lumefantrine for enhanced efficacy.
• Proven Efficacy: Clinically proven to be effective against P. falciparum malaria, including resistant strains.
• Convenient Dosage: Adults should take 2 tablets initially, followed by 2 tablets after 8 hours, then 2 tablets twice daily for the next 2 days (total of 12 tablets).

Recommended Use

• Dosage: Adults: Follow the specified regimen for effective treatment against simple malaria caused by P. falciparum.

R-Lume 40/240 stands out as a reliable choice for combating malaria, offering superior effectiveness and safety supported by global health recommendations.